Romosozumab 68225-0102
Product NDC
68225-0102- Manufacturer
- Patheon Italia S.p.a.
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- April 9, 2019
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Romosozumab | 105 mg/1.17mL |
Packaging Options(1)
12 CASE in 1 CONTAINER (68225-102-00) / 88 TRAY in 1 CASE / 20 SYRINGE in 1 TRAY / 1.17 mL in 1 SYRINGE